Sarepta Therapeutics Inc. (SRPT) Fundamentals

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
SHARE INFORMATION
Market Cap$ 9,761,189,020
Shares Outstanding87,567,857
Float83,695,962
Percent Float95.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 701,887,000
Latest Fiscal EPS$ -5.15
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions792
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months8,972,759
Institutional Holdings Percent147.5%
Institutional Sold Previous 3 Months15,170,628
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months103,270
Insider Holdings Percent17.6
Insider Sold Previous 3 Months-
Insider Shares Owned15,447,401
TRADING INFO
52 Week High$ 120.23
52 Week Low$ 61.28
52 Week High Change$ 17.76
21 Day Moving Average$ 111.2157
21 Day Extended Moving Average$ 110.0552
50 Day Moving Average$ 107.4386
50 Day Extended Moving Average$ 105.0608
200 Day Moving Average$ 84.4252
200 Day Extended Moving Average$ 90.1892
10 Day Average Volume805,762
20 Day Average Volume1,266,797
30 Day Average Volume1,110,855
50 Day Average Volume1,173,339
Alpha0.021491
Beta1.1232
Standard Deviation0.168493
R20.120809
7 Day Price Change$ 3.14
7 Day Percent Change2.9%
21 Day Price Change$ 6.31
21 Day Percent Change6.0%
30 Day Price Change$ 2.09
30 Day Percent Change1.91%
Month to Date Price Change$ 0.93
Month to Date Percent Change0.84%
Quarter to Date Price Change$ 0.93
Quarter to Date Percent Change0.84%
180 Day Price Change$ 25.85
180 Day Percent Change30.19%
200 Day Price Change$ 30.43
200 Day Percent Change37.55%
Year to Date Price Change$ 21.42
Year to Date Percent Change23.79%

Sarepta Therapeutics Inc. (SRPT) Key Ratios

PROFITABILITY
EBIT Margin-52.5%
EBITDA Margin-47.5%
Pre-Tax Profit Margin-100.5%
Profit Margin Count-71.0%
Gross Margin85.1%
Profit Margin TOT-71.0%
INCOME STATEMENTS
Revenue$ 645,778,000
Revenue Per Share$ 7.3746
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book13.30
Total Debt To Equity1.60
Int Coverage-6.90
Current Ratio4.50
Leverage Ratio3.20
Quick Ratio4.00
Long Term Debt To Capital0.61
VALUATION MEASURES
PE Ratio-18.70
Enterprise Value$ 8,839,432,198
Price to Sales15.1154
Price to Free Cash-45.00
PE High Last 5 Years-10.50
Price To Book13.30
Price To Cash Flow54.10
PE Low Last 5 Years-61.80
Price to Tangible Book13.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.50
Invoice Turnover0.30
Assets Turnover0.10
Return Assets-17.60
Return on Equity-83.63
Return on Capital-26.78

Sarepta Therapeutics Inc. (SRPT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEODouglas S. Ingram
Emplyoees840
Last AuditUE
CIK0000873303
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address215 First Street
Suite 415
Cambridge, MA 2142
Websitehttps://www.sarepta.com
Facsimile+1 800 621-5203
Telephone+1 617 274-4000
Emailiestepan@sarepta.com


Your Recent History
NASDAQ
SRPT
Sarepta Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.